Held by 243 funds across 17 fund houses in our coverage.
Coverage: 22 of India's largest fund houses — growing.
As of the latest monthly AMC disclosures, Sun Pharmaceutical Industries is held by 243 mutual funds and ETFs in our database. The total value of equity held across these schemes is ₹44,160 Cr. Among all holding funds, the manager with the highest conviction is Nippon India Nifty Pharma ETF (Nippon India MF), which allocates a significant 24.92% of its entire portfolio to Sun Pharmaceutical Industries.
In terms of category distribution, ETF funds hold the largest exposure by market value, representing 40 positions. Across different fund houses, ICICI Pru MF manages the largest aggregate stake, holding a combined value of ₹15,234 Cr. This distribution indicates whether the stock is favored by active diversified equity managers or is primarily held in sector-specific/thematic portfolios.
Portfolios as on: Nippon India MF Apr 2024 · ICICI Pru MF Jul 2026 · Aditya Birla SL MF Apr 2026 · DSP MF Jul 2026 · Kotak MF Jul 2026 · Motilal Oswal MF Jul 2026 · SBI MF Jul 2026 · LIC MF Jul 2026 · UTI MF Jul 2026 · Franklin Templeton MF Jul 2026 · HDFC MF Jul 2026 · NJ MF Aug 2025 · Groww MF Oct 2025 · Mirae Asset MF Jul 2026 · ITI MF Jul 2026 · Axis MF Jul 2026. ISIN-verified equity positions from public AMC disclosures. Not investment advice.
Weight = the position as a % of that fund's portfolio. MoM = change vs the previous month's disclosure. Values in ₹: L = Lakh (1,00,000), Cr = Crore (1,00,00,000).